Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New advances in Alzheimer's disease treatment, prevention and diagnosis

March 24, 1997

Bay-x-3702: Neuroprotective 5-HT1A receptor agonist from Bayer

March 24, 1997

Dual NOS/COX inhibitors claimed by SCRAS

March 24, 1997

New salts of known antimigraine agent from Glaxo Wellcome

March 24, 1997

5-HT1A antagonists from American Home Products

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Quadramet enters phase I for arthritis

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

3-D structure of adenylyl cyclase core determined

March 21, 1997

Sagami prepares angiotensin IV agonists

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...